Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 1, 2010, Pages 32-42

  Gyarmathy, V Anna ^a,b   Neaigus, Alan ^c   Li, Nan ^b   Ujhelyi, Eszter ^d   Caplinskiene, Irma ^e,f   Caplinskas, Saulius ^e,f   Latkin, Carl A ^b  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Department of Medicine   (United States)

^d Szent Lszl Hospital   (Hungary)

^e Centre for Communicable Diseases Prevention and Control   (Lithuania)

^f M Romeris University   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DRUG USE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNGARY; LITHUANIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SELF REPORT; SYRINGE;

ADULT; DISCLOSURE; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; HUNGARY; LITHUANIA; MALE; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 78650257658     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.513064     Document Type: Article

References (27)

1. Mayfield Arnold E, Rice E, Flannery D, Rotheram-Borus MJ. HIV disclosure among adults living with HIV. AIDS Care 2008;20:80-92.
2. Latkin CA, Knowlton AR, Forman VL, Hoover DR, Schroeder JR, Hachey M, Celentano DD. Injection drug users disclosure of HIV seropositive status to network members. AIDS Behav 2001;5:297-305.
3. Parsons JT, Missildine W, Van Ora J, Purcell DW, Gó m ez CA. Seropositive Urban Drug Injectors Study. HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care STDS 2004;18:457-69.
4. Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 2002;97:1289-94.
5. Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis 2002;35:783-8.
6. Gyarmathy VA, Neaigus A, Mitchell MM, Ujhelyi E. The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary. Drug Alcohol Depend 2009;100:240-7.
7. De P, Cox J, Boivin JF, Platt RW, Jolly AM, Alexander PE. HIV and HCV discordant injecting partners and their association to drug equipment sharing. Scand J Infect Dis 2009;41:206-14.
8. Neaigus A. The network approach and interventions to prevent HIV among injection drug users. Public Health Rep 1998;113:140-50.
9. Gyarmathy VA, Li N, Tobin KE, Hoffman IF, Sokolov N, Levchenko J, et al. Injecting equipment sharing in Russian drug injecting dyads. AIDS Behav 2010;14:141-51.
10. Valente TW, Vlahov D. Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health 2001;91:406-11.
11. Granovetter M. The strength of weak ties: a network theory revisited. Sociol Theor 1983;1:201-33.
12. Elford J, Ibrahim F, Bukutu C, Anderson J. Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defi c Syndr 2008;47:514-21.
13. Wikipedia. Hungary. Available at: http://en.wikipedia.org/ wiki/Hungary (accessed 20 November 2009).
14. Wikipedia. Lithuania. Available at: http://en.wikipedia.org/ wiki/Lithuania (accessed 20 November 2009).
15. European Monitoring Centre for Drugs and Drug Addiction. Statistical Bulletin 2008. Available at: http://www.emcdda. europa.eu/stats08 (accessed 3 September 2010).
16. Gossop M, Griffi ths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992;87:1527-36.
17. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
18. Schlumberger MG, Desenclos JC, Papaevangelou G, Richardson SC, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users. Eur J Epidemiol 1999;15:207-15.
19. Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, et al. Informed altruism and partner restriction in the reduction of HIV infection in injecting drug users entering detoxifi cation treatment in New York City, 1990-2001. J Acquir Immune Defi c Syndr 2004;35:158-66.
20. D esenclos JC, Papaevangelou G, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. AIDS 1993;7:1371-7.
21. Vidal-Tr é can G, Coste J, Varescon-Pousson I, Christoforov B, Boissonnas A. HCV status knowledge and risk behaviours amongst intravenous drug users. Eur J Epidemiol 2000;16: 439-45.
22. Golub ET, Strathdee SA, Bailey SL, Hagan H, Latka MH, Hudson SM, et al. Distributive syringe sharing among young adult injection drug users in fi ve U.S. cities. Drug Alcohol Depend 2007;91(Suppl 1):S30-8.
23. Rhodes T, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction 2004;99:621-33.
24. Gyarmathy VA, Neaigus A, Ujhelyi E, Szabó T, R ác z J. Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors. Drug Alcohol Depend 2006;82:S65-9.
25. Noden BH, Gomes A, Ferreira A. Influence of religious affi liation and education on HIV knowledge and HIV-related sexual behaviors among unmarried youth in rural central Mozambique. AIDS Care 2010;1-10.
26. Paterson BL, Backmund M, Hirsch G, Yim C. The depiction of stigmatization in research about hepatitis C. Int J Drug Policy 2007;18:364-73.
27. Rác z J, Gyarmathy VA, Neaigus A, Ujhelyi E. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 2007;19:- 66.